This page is available in multiple languages
Select Language

EnterNext welcomes Oncodesign on Alternext in Paris


Philippe Genne, CEO of Oncodesign, opens the European trading day in Paris.

Oncodesign specializes in the research and development of drugs for the treatment of cancer. The group provides preclinical pharmacological evaluation services in the oncology field.